Well, this is optimism for you..11 Nov 2021 08:18
I like this bit - 'I look forward to updating you early in 2022 on the topline results. In the meantime, I encourage everyone to follow, like and share our official news posts on LinkedIn and Twitter (@synairgenplc) with your friends and contacts.'
Dear colleagues, partners, and friends,
I am excited to share the news with you that we have hit our recruitment target of 610 patients randomised in our Phase 3 SPRINTER trial for hospitalised patients with COVID-19. You can read the press release here.
This is an important milestone for Synairgen, and a step closer to a potential new and effective treatment for those hospitalised with COVID-19, bringing new hope for recovery.
It reinforces that the timing of our top line results data readout due in early 2022 remains on track. And timing matters. With thousands of people a day in the US alone requiring hospitalisation, more treatment options are urgently needed, and we are proud to be contributing to this fight and delighted to be within sight of the finish line for the SPRINTER trial.
It also marks the end of an extraordinary period for the Synairgen clinical team led by Jody Brookes and the many partners we have been working with during this time. Thank you to the Synairgen clinical team, the trial sites and investigators, as well as our partners at Paraxel Bio, Data Magik, Transcrip, Aerogen and Veramed who have all worked as part of our team to bring this trial one step closer to conclusion. You can view a short video from Jody here.
Finally, and importantly, I would like to say a huge thank you the nurses, doctors, and especially the patients who volunteered to be part of this trial. Without them, this wouldn’t have been possible.
I look forward to updating you early in 2022 on the topline results. In the meantime, I encourage everyone to follow, like and share our official news posts on LinkedIn and Twitter (@synairgenplc) with your friends and contacts.
With thanks,
Richard
Richard Marsden
CEO
Synairgen plc
Mailpoint 810
Southampton General Hospital
Southampton
SO16 6YD
Sign In
Follow the stocks
